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Molecular Characterization of High-Level-Cholera-Toxin-Producing El
Tor Variant Vibrio cholerae Strains in the Zanzibar Archipelago of
Tanzania
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Welfare, Zanzibar, Tanzaniae; Public Health Laboratory, Pemba, Zanzibar, Tanzaniaf
Analysis of 1,180 diarrheal stool samples in Zanzibar detected 247 Vibrio choleraeO1, Ogawa strains in 2009. Phenotypic traits
and PCR-based detection of rstR, rtxC, and tcpA alleles showed that they belonged to the El Tor biotype. Genetic analysis of ctxB
of these strains revealed that they were classical type, and production of classical cholera toxin B (CTB) was confirmed byWest-
ern blotting. These strains producedmore CT than the prototype El Tor and formed a separate cluster by pulsed-field gel electro-
phoresis (PFGE) analysis.
Cholera infection continues to be a substantial health burden indeveloping countries, due to lack of proper hygiene and san-
itation infrastructure, especially in Africa and Asia. There was no
published report of cholera in Africa for more than a century, until
the disease struck western regions in 1970. It quickly spread and
became endemic across much of the continent, killing hundreds
of people each year. The incidence of cholera increased steadily
from 2010 to 2011, and the number of deaths increased by 3.5%.
Cholera statistics released recently by the WHO show an 85%
increase in the number of reported cholera cases in 2011 com-
pared to the previous year (1). Recent cholera outbreaks in Cam-
eroon, Haiti, and Zimbabwe (2–4) provide an indication of the
alarming increase in the incidence of cholera, making it a major
disease in the global public health scenario.
Cholera is caused by the Gram-negative bacteriumVibrio chol-
erae. V. cholerae strains are classified into over 200 serogroups.
The O1 serogroup is further classified into two biotypes, namely,
classical and El Tor. Seven times since 1817, cholera has spread
across the world in the form of pandemics. There is firm evidence
that the fifth and sixth pandemics of cholera were caused by the
classical biotype, while the most extensive and ongoing seventh
pandemic, which started in 1961, is caused by the El Tor biotype
(5). Reports of new variant strains ofV. cholerae, which have char-
acteristics of both the El Tor and classical biotypes, appeared first
in 2002 (6) and then in 2004 (7). Studies from Asia and Africa
revealed the emergence and dissemination of classical ctxB in El
Tor biotype strains, which replaced the seventh-pandemic El Tor
prototype strains in most of the areas where cholera is endemic
(8–15).
Zanzibar, an archipelago off the coast of east Africa, consists of
two major islands, Unguja (also named Zanzibar) and Pemba.
They are situated in the Indian Ocean about 40 to 60 km off the
coast of mainland Tanzania and have a population of about 1.1
million. During 2009, an increased number of cases occurred in
the United Republic of Tanzania, with 7,700 cases being reported,
compared with 2,911 in the previous year (15a). Cholera’s incur-
sion into Haiti after an absence of almost 100 years (16) and the
rapidly growing genetic diversity among toxigenic V. cholerae
strains with epidemic potential provided the impetus for molecu-
lar characterization of strains collected in Zanzibar in 2009. We
put a special emphasis on cholera toxin (CT) genotypes along with
the CTX prophages of the V. cholerae strains isolated from Zanzi-
bar to understand whether the emerging El Tor variant has dis-
seminated in this isolated region.
(Part of this article was presented at the 45th Annual Joint
Panel Meeting on Cholera and Other Bacterial Enteric Infections,
organized by the United States-Japan Cooperative Medical Sci-
ence Program, at Kyoto, Japan, 6 to 8 December 2010.)
This study was part of a surveillance program of mass oral
cholera vaccination in high-risk populations in Zanzibar sup-
ported by the International Vaccine Institute of South Korea, the
WHO, and the Zanzibari Ministry of Health and Social Welfare.
Stool samples were collected from patients with acute watery di-
arrhea from March to November 2009 at four health care centers
on Unguja (Chumbuni, Akbar, Kundi, and Mnazi Moja Hospi-
tal), five centers on Pemba (Shamiani, Kengeja, Mwambe, Mtam-
bili, and Mkoani), and a number of temporary cholera camps set
up by the government in response to suspected outbreaks. Among
the 1,180 samples collected from patients with acute diarrhea, 268
samples were positive forV. cholerae. Serotyping results with poly-
valent O1, monospecific Ogawa, and Inaba antisera (each from
Difco Laboratories, Detroit, MI) and monoclonal O139 antiserum
(16a) established that 247 of the total V. cholerae isolates belonged
to the Ogawa serotype and the remaining 21 isolates were non-O1
non-O139. An isolation profile organized according to month
showed that there was a sudden increase in the isolation of V.
cholerae O1 in July and September. We restricted our study to the
O1 strains obtained in this study. All strains tested were resistant
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to polymyxin B and positive in the Voges-Proskauer test, suggest-
ing that they were phenotypically El Tor.
Analysis of biotype-specific ctxB.The ctxB gene of theV. chol-
erae O1 strains, which encodes the cholera enterotoxin B subunit,
was examined with biotype-specific primers as described else-
where (17). Results from mismatch amplification mutation assay
(MAMA)-PCR showed that all the strains (Fig. 1) had the classical
ctxB allele in their CTX prophage. Reports of the emergence of
novel variants ofV. choleraeO1 El Tor strains with an additionally
mutated CTB (9, 18, 19) prompted us to further characterize the
ctxB allele of 50 representative strains, which yielded positive am-
plicons for classical ctxB gene in MAMA-PCR. As described in our
last report (19), we used a double mismatch amplification muta-
tion assay (DMAMA) for this study. Our DMAMA results to-
gether with DNA sequence analysis data also confirmed our initial
MAMA PCR results. The deduced amino acid sequences of the
strains were found to be identical to the classical CTB (GenBank
accession numbers JQ683131 to JQ683136), with a histidine at
position 39 and a threonine at position 68. N16961 and O395 were
used as El Tor and classical reference strains in all cases.
Studies of other biotype-specific markers. Further genetic
characterization based on earlier studies (5, 14, 20–24) with prim-
ers specific for genes encoding the RS1 element antirepressor
RstC, the transcriptional repressor RstR, toxin coregulated pilus
subunit A, and repeat in toxin C subunit (rstC, rstR, tcpA, and
rtxC, respectively) was employed to confirm the biotype of the
Zanzibar isolates. Table 1 summarizes our PCR results, which ge-
netically characterize all of the 247 O1 isolates as El Tor biotype.
Further PCR analysis with primers from different genetic seg-
ments of the CTX prophage and its downstream region confirmed
the presence of intact an RS1 element upstream of the CTX pro-
phage. All of the tested strains were positive for the toxin-like
cryptic element (tlc). All of the primers used in this study have
been enlisted in Table 2.
Analysis of the ctxApromoter region.Sequence analysis of the
ctxApromoter region of representativeV. choleraeO1 strains from
Zanzibar revealed the presence of three tandem TTTTGAT hep-
tanucleotide repeats. These repeat regions play an important role
for binding the transcriptional activators ToxR (28, 29) and ToxT
(30, 31). The analysis of the ctxA promoter region of V. cholerae
O1 isolates from Kolkata showed 4 repeat units (Fig. 2).
Chromosomal localization of CTX prophage along with its
organization. All tested strains from Zanzibar yielded an ampli-
con of 766-bp in a PCR using CII-F and CII-R primers (Fig. 3A).
CII-F and CII-R primers flank the predicted CTX prophage inte-
gration site in the small chromosome of V. cholerae (27). The
presence of a 766-bp amplicon indicated that the small chromo-
some of the Zanzibar strains was devoid of any CTX prophage in
the usual position. The primers would have failed to amplify a
DNA segment of around 7.8 kb under the PCR conditions used if
there had been a single copy of CTX prophage in this region, as
was the case with O395. Analysis of these sequencing data revealed
that there are neither any remnants of CTX prophage nor any
indication of mobility in this site. Furthermore, it also showed the
precise location of CTX prophage insertion in the small chromo-
some of classical reference strain O395. Strains which lack a CTX
prophage in their small chromosomes (e.g., 2010EL-1786, M66-2,
and IEC224) shared 99 to 100% sequence identity in this specific
region with the Zanzibar strains. The primers rstC1 and rtxA1
yielded an9-kb amplicon (using the XT 20 PCR system; Banga-
lore Genei, Bangalore, India) DNA fragment (Fig. 3B), suggesting
that V. cholerae O1 isolates from Zanzibar probably had a single
copy of the CTX prophage. Figure 3C shows a schematic diagram
of the copy number of CTX prophages with probable combina-
tions of rstR and ctxB alleles in the Zanzibar strains.
Measurement of CT production by bead ELISA and confir-
mation of production of classical CT by the Zanzibar strains.
The amount of CT produced was measured as described previ-
ously (32, 33) during the growth of the representative strains from
Zanzibar in AKI medium and compared with prototype El Tor
and classical strains. It was found that all the El Tor variant strains
from Zanzibar produced significantly larger amounts of CT in
vitro than most strains of prototype El Tor (P  0.001, Mann-
Whitney U test) (Fig. 4A). Most of the El Tor strains produced
100 ng/ml/unit of optical density at 600 nm (OD600), while all
the classical strains produced 900 ng/ml/OD600 unit. Western
blot analysis using a CTB-specific monoclonal antibody also
FIG 1 MAMA-PCR to detect the type of ctxB allele in representative Vibrio
cholerae O1 strains isolated from the Zanzibar archipelago in Tanzania using
primers (Fw-con/Rv-cla) for the classical ctxB allele (top) and Fw-con/Rv-elt
for the El Tor ctxB allele (bottom). Lane 1, MCM 32; lane 2, MCM 133; lane 3,
MCM 134; lane 4, MCM 146; lane 5, MCM 168; lane 6, T1; lane 7, MCF 084;
lane 8, MCF 001; lane 9, WF 01; lane 10, 210200; lane 11, classical control
(0395); lane 12, El Tor control (N16961).
TABLE 1 Genetic characterization of the V. cholerae O1 strains isolated from samples from Zanzibar
Strain tested Serogroup Serotype Biotype
PCR result for target genea
ctxB rstR tcpA rstC rtxC tlc
Zanzibar O1 Ogawa El Tor C E E   
N16961 O1 Inaba El Tor E E E   
O395 O1 Ogawa Classical C C C   
a C, classical; E, El Tor.
Analysis of V. cholerae in Zanzibar
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showed that the Zanzibar isolates produced classical CTB
(Fig. 4B).
Molecular typing by pulsed-field gel electrophoresis (PFGE).
PFGE analysis of 16 representative strains from Zanzibar along
with several reference strains from other parts of the world
showed that the Zanzibar strains formed a homogeneous banding
pattern (except one strain), and this pattern is different from In-
dian and other African strains isolated recently (Fig. 5). Dendro-
gram analysis using Bionumeric software (Applied Maths, Bel-
gium) showed that the Zanzibar strains formed a separate cluster,
indicating their different lineage (Fig. 5).
Cholera is endemic mainly in low-income countries in Africa,
Asia, and Central and South America. In recent years, it has be-
come endemic in an increasing number of geographical areas. In
Zanzibar, a cholera outbreak with 411 cases and 51 deaths was
reported for the first time in 1978 from a fishing village (34).
Before the present study, we had very limited knowledge about the
molecular epidemiology of V. cholerae isolated from these regions
although recurrent outbreaks have been documented since 1978.
To our knowledge, this is the first study at the molecular level of
cholera epidemiology in the archipelago. A growing number of
published articles indicate that the V. cholerae O1 El Tor variant
strains have replaced the seventh-pandemic El Tor biotype strains
in many areas in Africa and Asia. Siddique et al. found in a clinical
study that large numbers of patients were admitted with severe
dehydration in Bakerganj and Mathbaria hospitals in southern
Bangladesh and that all the V. cholerae O1 El Tor strains isolated
from these patients produced classical CT (35). Two recently pub-
lished reports (32, 33) also motivated us to speculate that a signif-
icant difference between the amounts of CT produced by strains of
TABLE 2 Primer sequences, amplicon sizes, and annealing conditions used in PCR assays
Primera Primer sequence (5=–3=) Amplicon size (bp) Annealing temp (°C) Reference
rtxA1 GCGATTCTCAAAGAGATGC 2,400 54 24
Fw-con ACTATCTTCAGCATATGCACATGG 17
Rv-elt CCTGGTACTTCTACTTGAAACA 55
Rv-cla CCTGGTACTTCTACTTGAAACG 191
ctxB-F3 GTTTTACTATCTTCAGCATATGCGA 56 19
ctxB-F4 GTTTTACTATCTTCAGCATATGCGC 60
ctxB (F) GGTTGCTTCTCATCATCGAACCAC 460 25
ctxB (R) GATACACATAATAGAATTAAGGAT 55
rstRclass (F) CTTCTCATCAGCAAAGCCTCCATC 474 50 26
rstRET (F) GCACCATGATTTAAGATGCTC 501
rstA3R TCGAGTTGTAATTCATCAAGAGTG
CIIF CTCACGCTGAACAGCAAGTC 766 55 27
CIIR TTGCTTGAATCGAAAGGACA
tlc (F) GATTGTGCG TCTTGCATTTAGG 2,011 55 27
tlc (R) GTGAATAAATCAGGTGTAATGTCG
cep (R) TTTAGCCTTACGAATTAAGCC 3,047
rstC1 AACAGCTACGGGCTTATTC 245 55 24
rstC2 TGAGTTGCGGATTTAGGC
zotF(S) CGAGCTACCGCTACAAGGTGCTA 470 55 This study
ctxAR(S) CGTGCCTAACAAATCCCGTCTGAG
a F, forward; R, reverse.
FIG 2 Comparative nucleotide sequence analysis of the promoter region the ctxAB operon (PctxAB) of Zanzibar isolate MCM 133 and Kolkata isolate CRC 220.
The nucleotide sequences of PctxAB of O395 (classical control strain) and N16961 (El Tor control strain) were obtained from GenBank. Identical residues are
indicated with dots. Each solid bar indicates the missing TTTTGAT heptads. The black arrow line represents the ATG start codon of ctxA gene. The Zanzibar
isolate lacks one more heptad repeat than the Kolkata isolate.
Naha et al.
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these two biotypes may reflect the severity of clinical manifesta-
tion.
The selection of the El Tor variant strain seems to be an evolu-
tionary optimization of the El Tor biotype and could represent a
new, more virulent form of the El Tor biotype. It would be inter-
esting to know the lineages of the Zanzibar strains, as the specific
change in ctxB of El Tor strains was first observed in Kolkata dur-
ing 1990 (13). These new V. cholerae O1 El Tor variant strains not
only replaced the V. cholerae O1 El Tor prototype strains but also
turned out to be genetically stable and spread rapidly even to re-
FIG 3 PCR results implicating the chromosomal organization of the CTX prophage of Vibrio cholerae O1 Ogawa isolates from Zanzibar. (A) PCR results with
primers CII F and CII R showing the absence of the CTX prophage in chromosome II of Zanzibar isolates. The two black bars indicate the locations of the two
primers. Lane M, 100-bp DNA ladder; lane 1, MCM 32; lane 2, MCM 133; lane 3, MCM 134; lane 4, MCM 146; lane 5, MCM 168; lane 6, T1; lane 7, MCF 084;
lane 8, MCF 001. El Tor control strain N16961 and classical control strain O395 were used as positive and negative controls, respectively. (B) Agarose gel
electrophoresis showing the results of PCR with primers rstC1 and rtxA1. Lane L, lambda-HindIII DNA ladder; lane 1, MCM 133; lane 2, MCM 168; lane 3, KM
282; lane 4, T1; lane 5, WM 012; lane M, 1-kb DNA ladder. (C) Predicted molecular organization of the CTX prophage of V. cholerae isolates from Zanzibar with
a probable combination of rstR and ctxB in their large chromosome. The black bars indicate the locations of the two primers rstC1 and rtxA1.
FIG4 (A) Amounts of cholera toxin production by Zanzibar variants, prototype El Tor strains, and the classical strain. Error bars show standard errors for results of tests
done in triplicate. (B) Western immunoblotting results of the culture supernatant of representative Zanzibar O1 isolates. Samples of 100 ng each of the purified classical
CT (lane 1) and El Tor CT (lane 2) were used as positive controls for immunoblotting with the monoclonal antibody against classical and El Tor CTB, respectively. Lane
3, CF04; lane 4, MCF147; lane 5, MCF100; lane 6, MCM79; lane 7, medium only (negative control). Numbers at left are molecular masses, in kilodaltons.
Analysis of V. cholerae in Zanzibar
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mote islands off the eastern coast of Africa, as evidenced by this
study. Moreover, the severity of the disease appears to be intensi-
fying, and recent cholera outbreaks in various places, including
Zimbabwe and Haiti, have been protracted (3, 36). An active
holistic surveillance system should be in place in order to track the
dissemination of the V. cholerae O1 El Tor variant strains in the
population using the latest molecular diagnostic assays, as these
strains possess all the necessary characteristics for a new pan-
demic. Moreover, a recent study by Reyburn et al. (4) provided
evidence from the temporal patterns of cholera cases reported
between 2002 and 2008 in Zanzibar that rainfall and temperature,
among various climate and ocean environmental factors, are the
key drivers of cholera outbreaks. Such predictive models may help
public health authorities to prepare medical equipment, mobilize
staff, and stock and distribute mass oral cholera vaccines.
Nucleotide sequence accession numbers. Nucleotide se-
quences of the rstR gene from a representative strain have been
deposited in GenBank under the accession numbers JX312666 to
JX312670. The nucleotide sequences of the ctxA promoter region
of five Zanzibar isolates have been deposited in GenBank under
the accession numbers JX144324 to JX144328. The nucleotide se-
quences of the 766-bp region from five Zanzibar isolates have been
deposited in GenBank under the accession numbers JX255488 to
JX255492.
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